IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N43AI130014
Agency Tracking Number: N43AI130014
Amount: $210,507.00
Phase: Phase I
Program: SBIR
Awards Year: 2013
Solitcitation Year: 2013
Solitcitation Topic Code: NIAID
Solitcitation Number: N/A
Small Business Information
PROTEIN ADVANCES, INC.
PROTEIN ADVANCES, INC., 1102 Columbia Street Ste 110, SEATTLE, WA, 98104-2025
Duns: 148051621
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 DARRICK CARTER
 (206) 623-0331
 DARRICK.CARTER@PROTEINAI.COM
Business Contact
 DARRICK CARTER
Phone: (206) 623-0331
Email: DARRICK.CARTER@PROTEINAI.COM
Research Institution
 Stub
Abstract
Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ). PUBLIC HEALTH RELEVANCE

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government